282 related articles for article (PubMed ID: 18756919)
1. Treatment of cancer-related anemia.
Badzek S; Curić Z; Krajina Z; Plestina S; Golubić-Cepulić B; Radman I
Coll Antropol; 2008 Jun; 32(2):615-22. PubMed ID: 18756919
[TBL] [Abstract][Full Text] [Related]
2. The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
[TBL] [Abstract][Full Text] [Related]
3. Role of epoetin in the management of anaemia in patients with lung cancer.
Morère JF
Lung Cancer; 2004 Nov; 46(2):149-56. PubMed ID: 15474662
[TBL] [Abstract][Full Text] [Related]
4. [Erythropoietin].
Kubanek B; Rich I; Noé G
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():46-50. PubMed ID: 7531047
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
Desai J; Demetri GD
Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
[TBL] [Abstract][Full Text] [Related]
6. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
7. The role of recombinant erythropoietin in childhood cancer.
Shankar AG
Oncologist; 2008 Feb; 13(2):157-66. PubMed ID: 18305061
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
[TBL] [Abstract][Full Text] [Related]
9. rHuEPO and improved treatment outcomes: potential modes of action.
Blackwell K; Gascón P; Sigounas G; Jolliffe L
Oncologist; 2004; 9 Suppl 5():41-7. PubMed ID: 15591421
[TBL] [Abstract][Full Text] [Related]
10. [Anemia in lung cancer patients].
Méric JB; Morère JF;
Bull Cancer; 2005 May; 92(5):439-44. PubMed ID: 15932807
[TBL] [Abstract][Full Text] [Related]
11. Anemia in the setting of cancer and human immunodeficiency virus.
Levine AM
Clin Infect Dis; 2003; 37 Suppl 4():S304-14. PubMed ID: 14581999
[TBL] [Abstract][Full Text] [Related]
12. Anemia of cancer: pathogenesis and treatment with recombinant erythropoietin.
Mittelman M
Isr J Med Sci; 1996 Dec; 32(12):1201-6. PubMed ID: 9007154
[TBL] [Abstract][Full Text] [Related]
13. EPO in cancer anemia: benefits and potential risks.
Milano M; Schneider M
Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
[TBL] [Abstract][Full Text] [Related]
14. Treatment options for anemia, taking risks into consideration: erythropoiesis-stimulating agents versus transfusions.
Spano JP; Khayat D
Oncologist; 2008; 13 Suppl 3():27-32. PubMed ID: 18458122
[TBL] [Abstract][Full Text] [Related]
15. Alfa-epoietin and anaemia in gynaecological cancer.
Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
[TBL] [Abstract][Full Text] [Related]
16. To give or not to give recombinant EPO to anemia endangered cancer patients.
Sulkowska M; Wincewicz A; Chabowska A; Kanczuga-Koda L; Szymanska M; Koda M; Witkowska E; Sulkowski S
Prague Med Rep; 2006; 107(3):281-9. PubMed ID: 17385400
[TBL] [Abstract][Full Text] [Related]
17. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
18. [Approaches to anemia, thrombocytopenia, and DIC in cancer patients].
Matsushita T
Gan To Kagaku Ryoho; 2006 Jan; 33(1):6-12. PubMed ID: 16410690
[TBL] [Abstract][Full Text] [Related]
19. Epoetin alfa: basic biology and clinical utility in cancer patients.
Littlewood T; Collins G
Expert Rev Anticancer Ther; 2005 Dec; 5(6):947-56. PubMed ID: 16336085
[TBL] [Abstract][Full Text] [Related]
20. Epoetin beta therapy in patients with solid tumours.
Pronzato P; Jassem J; Mayordomo J
Crit Rev Oncol Hematol; 2006 Apr; 58(1):46-52. PubMed ID: 16169242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
